André Robidoux
- Cancer Research top 0.05%
- Breast Cancer Treatment Studies 46
- Oncology top 0.1%
- Cancer Treatment and Pharmacology 27
- HER2/EGFR in Cancer Research 25
- Cancer Risks and Factors 11
- Cancer survivorship and care 8
- Pathology and Forensic Medicine top 0.1%
- Breast Lesions and Carcinomas 14
- Genetics top 0.2%
- BRCA gene mutations in cancer 12
- Estrogen and related hormone effects 9
- Reproductive Medicine top 1%
- Co-authors
- Norman WolmarkJoseph P. CostantinoD. Lawrence WickerhamJames N. AtkinsBernard FisherEleftherios P. MamounasVictor G. VogelWalter M. Cronin
- Journals
- Journal of Clinical Oncology (29 papers)Breast Cancer Research and Treatment (10 papers)The Lancet Oncology (6 papers)
- Partner nations
- CanadaUnited StatesBelgium
In The Last Decade
André Robidoux
88 papers receiving 14.3k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Cancer Research 8.0k
- Oncology 7.7k
- Pathology and Forensic Medicine 4.1k
- Genetics 4.4k
- Reproductive Medicine 657
Countries citing papers authored by André Robidoux
This map shows the geographic impact of André Robidoux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Robidoux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Robidoux more than expected).
Fields of papers citing papers by André Robidoux
This network shows the impact of papers produced by André Robidoux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Robidoux. The network helps show where André Robidoux may publish in the future.
Co-authorship network
The 25 scholars most cited alongside André Robidoux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2020 | 33 | |
| 3 | 2019 | 24 | |
| 4 | 2019 | 279 | |
| 5 | 2017 | 70 | |
| 6 | 2015 | 19 | |
| 7 | 2013 | 64 | |
| 8 | 2013 | 261 | |
| 9 | 2013 | 49 | |
| 10 | 2013 | 23 | |
| 11 | 2010 | 438 | |
| 12 | 2010 | 3 | |
| 13 | 2009 | 18 | |
| 14 | 2009 | 36 | |
| 15 | 2009 | 47 | |
| 16 | 2008 | 17 | |
| 17 | 2008 | 8 | |
| 18 | 2007 | 27 | |
| 19 | Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Studybreakdown → | 2005 | 937 |
| 20 | 2001 | 20 |
About André Robidoux
André Robidoux is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 89 papers that have together received 14.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (46 papers), Cancer Treatment and Pharmacology (27 papers), HER2/EGFR in Cancer Research (25 papers), Breast Lesions and Carcinomas (14 papers), BRCA gene mutations in cancer (12 papers), Cancer Risks and Factors (11 papers), Estrogen and related hormone effects (9 papers) and Cancer survivorship and care (8 papers). The work is most often cited by research in Cancer Research (8.0k citations), Oncology (7.7k citations) and Pathology and Forensic Medicine (4.1k citations). André Robidoux has collaborated with scholars based in Canada, United States and Belgium. Frequent co-authors include Norman Wolmark, Joseph P. Costantino, D. Lawrence Wickerham, James N. Atkins, Bernard Fisher, Eleftherios P. Mamounas, Victor G. Vogel, Walter M. Cronin, Leslie G. Ford and Maureen Kavanah. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, The Lancet Oncology, Clinical Breast Cancer and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.